Mid-Cap Stock Check: One to Buy, Two to Avoid

Mid-Cap Stock Check-Up: One's a Winner, Two are Headed for Trouble. We dissect Masco and Hologic's sluggish growth and fading returns, revealing why they might not be breakout stars. Then, discover why East West Bank, with its impressive US-Asia financial focus and strong growth metrics, is a mid-cap standout poised for continued success. Plus, learn why market volatility creates opportunities to re-evaluate your portfolio and focus on resilient, high-quality stocks. Hosted on Acast. See acast.com/privacy for more information.